Impact of gender on in-hospital outcomes following contemporary percutaneous intervention for peripheral arterial disease

Journal of Invasive Cardiology

Volumn 17, Issue 8, 2005, Pages 433-436

  Kawamura, Akio ^a   Piemonte, Thomas C ^a   Nesto, Richard W ^a   Bilazarian, Seth D ^a   Riskalla, Nabila S ^a   Chauhan, Manish S ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HIRULOG;

ARM; ARTERY DISEASE; ARTICLE; BLEEDING; BLOOD TRANSFUSION; CARDIOVASCULAR EQUIPMENT; CONTROLLED STUDY; FEMALE; GENDER; HUMAN; INTERVENTIONAL CARDIOVASCULAR PROCEDURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERIPHERAL VASCULAR DISEASE; RISK; SEX DIFFERENCE; SMOKING; STENT; TREATMENT OUTCOME; AGED; COMPARATIVE STUDY; FOLLOW UP; HOSPITAL PATIENT; INCIDENCE; METHODOLOGY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; RETROSPECTIVE STUDY;

AGED; ANGIOPLASTY, BALLOON; ARTERIAL OCCLUSIVE DISEASES; FEMALE; FOLLOW-UP STUDIES; HEMORRHAGE; HOSPITAL MORTALITY; HUMANS; INCIDENCE; INPATIENTS; MALE; PERIPHERAL VASCULAR DISEASES; RETROSPECTIVE STUDIES; SEX FACTORS; TREATMENT OUTCOME;

EID: 25144506726     PISSN: 10423931     EISSN: 15572501     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Jacobs AK. Coronary revascularization in women in 2003. Sex revisited. Circulation 2003;107:375-377.
2. Watanabe CT, Maynard C, Ritchie JL. Comparison of short-term outcomes following coronary artery stenting in men versus women. Am J Cardiol 2001;88:848-852.
3. Jacobs AK, Johnston JM, Haviland A, et al. Improved outcomes for women undergoing contemporary percutaneous coronary intervention. A report from the National Heart, Lung and Blood Institute dynamic registry. J Am Coll Cardiol 2002;39:1608-1614.
4. Peterson ED, Lansky AJ, Kramer J, et al. Effect of gender on the outcomes of contemporary percutaneous coronary intervention. Am J Cardiol 2001;88:359-364.
5. Athanasiou T, Al-Ruzzeh S, Stanbridge RD, et al. Is the female gender an independent predictor of adverse outcome after off-pump coronary artery bypass grafting? Ann Thorac Surg 2003;75:1153-1160.
6. Selvin E, Erlinger TP. Prevalence of and risk factors for peripheral arterial disease in the United States. Results from the national health and nutrition examination survey, 1999-2000. Circulation 2004;110:738-743.
7. Mays BW, Towne JB, Fitzpatrick CM, et al. Women have increased risk of perioperative myocardial infarction and higher long-term mortality rates after lower extremity arterial bypass grafting. J Vasc Surg 1999;29:807-813.
8. Frangos SG, Karimi S, Kerstein MD, et al. Gender does not impact infrainguinal vein bypass graft outcome. Surgery 2000;127:679-686.
9. Roddy SP, Darling RC III, Maharaj D, et al. Gender-related differences in outcome: an analysis of 5880 infrainguinal arterial reconstructions. J Vasc Surg 2003;37:399-402.
10. Chauhan MS, Ho KKL, Baim DS, et al. Effect of gender on in-hospital and one-year outcomes after contemporary coronary artery stenting. Am J Cardiol 2005;95:101-104.
11. Singh M, Lennon RJ, Darbar D, et al. Effect of peripheral arterial disease in patients undergoing percutaneous coronary intervention with intracoronary stents. Mayo Clin Proc 2004;79:1113-1118.
12. Krikorian RK, Kramer PH, Vacek JL. Percutaneous revascularization of lower extremity arterial disease in females compared to males. J Invasive Cardiol 1997;9:333-338.
13. Matsi PJ, Manninen HI. Complications of lower-limb percutaneous transluminal angioplasty: a prospective analysis of 410 procedures on 295 consecutive patients. Cardiovasc Intervent Radiol 1998;21:361-366.
14. Chauhan MS, Kuntz RE, Ho KKL, et al. Coronary artery stenting in the aged. J Am Coll Cardiol 2001;37:856-862.
15. Mandak JS, Blankenship JC, Gardner LH, et al. Modifiable risk factors for vascular access site complications in the IMPACT II trial of angioplasty with versus without eptifibatide. J Am Coll Cardiol 1998;31:1518-1524.
16. Cho L, Topol EJ, Balog C, et al. Clinical benefit of glycoprotein IIb/IIIa blockade with abciximab is independent of gender: pooled analysis from EPIC, EPILOG and EPISTENT trials. J Am Coll Cardiol 2000;36:381-386.
17. Trabattoni D, Bartorelli AL, Montorsi P, et al. Comparison of outcomes in women and men treated with coronary stent implantation. Cathet Cardiovasc Intervent 2003;58:20-28.
18. Kuchulakanti PK, Satler LF, Suddath WO, et al. Vascular complications following coronary intervention correlate with long-term cardiac events. Cathet Cardiovasc Intervent 2004;62:181-185.
19. Waksman R, King SB III, Douglas JS, et al. Predictors of groin complications after balloon and new-device coronary intervention. Am J Cardiol 1995;75:886-889.
20. Schnyder G, Sawhney N, Whisenant B, et al. Common femoral artery anatomy is influenced by demographics and comorbidity: implications for cardiac and peripheral invasive studies. Cathet Cardiovasc Intervent 2001;53:289-295.
21. Granger CB, Hirsh J, Califf RM, et al. Activated partial thromboplastin time and outcome after thrombolytic therapy for acute myocardial infarction: results from the GUSTO-I trial. Circulation 1996;93:870-878.
22. Allie D, Hall P, Shammas NW, et al. The Angiomax Peripheral Procedure Registry of Vascular Events trial (APPROVE): Inhospital and 30-day results. J Invasive Cardiol 2004;16:651-656.
23. Eggebrecht H, von Birgelen C, Naber C, et al. Impact of gender on femoral access complications secondary to application of a collagen-based vascular closure device. J Invasive Cardiol 2004;16:247-250.
24. Tavris DR, Gallauresi BA, Lin B, et al. Risk of local adverse events following cardiac catheterization by hemostasis device use and gender. J Invasive Cardiol 2004;16:459-464.